House Oversight panel to grill EpiPen CEO next week


The House Oversight will hold a hearing next Wednesday to grill the CEO of Mylan, the maker of EpiPens. 

{mosads}The more-than-400 percent increase in the price of EpiPens in recent years has drawn outrage from both sides of the aisle. 

Mylan CEO Heather Bresch, who is also the daughter of Sen. Joe Manchin (D-W.Va.), will now face questions from lawmakers next week. 

“There is justified outrage from families and schools across the country struggling to afford the high cost of EpiPens,” Chairman Jason Chaffetz (R-Utah) and the top Democrat, Rep. Elijah Cummings (Md.), said in a joint statement.

“We look forward to receiving answers next week from Mylan about its dramatic price hike for this life-saving medication.”

The lawmakers said the company has said it would begin to provide documents this week in response to a letter from the committee. 

Dr. Doug Throckmorton, a top official at the Food and Drug Administration (FDA), will also testify. Republicans in particular have put a focus on speeding up the FDA approval process to get more competition into the market as a solution to extreme price hikes. 

“We also plan to examine ways to encourage greater competition in the EpiPen market and to speed FDA’s approval of acceptable new generic applications,” Chaffetz and Cummings said. 

Democrats have generally also called for broader changes, like allowing Medicare to negotiate drug prices or putting new requirements on drug companies.

Tags Jason Chaffetz Joe Manchin
See all Hill.TV See all Video

Most Popular

Load more


See all Video